Dashboard
Manage Tickers

PODD


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

insulet-announces-20252028-financial-outlook-sees-revenue-projected-to-grow-at-a-cagr-of-20-at-constant-currency-rates-driven-by-continued-omnipod-adoption-and-geographic-expansion-adjusted-operating-margin-expected-to-expand-annually-by-100-basis-points-reflecting-operational-efficiencies-and-growing-scale-adjusted-diluted-eps-anticipated-to-grow-at-a-cagr-of-25-free-cash-flow-forecast-to-remain-strong-enabling-disciplined-reinvestment-in-innovation-and-scaling-globally
Insulet Announces 2025–2028 Financial Outl...
11/20/2025 17:32:31

Company announces strong long-range financial outlook for 2025–2028Introduces next-generation innovation pipeline to transform ...

peering-into-insulet-corps-recent-short-interest
Peering Into Insulet Corp's Recent Short I...
11/20/2025 16:00:42

1000-invested-in-insulet-15-years-ago-would-be-worth-this-much-today
$1000 Invested In Insulet 15 Years Ago Wou...
11/19/2025 14:15:35

ubs-upgrades-insulet-to-buy-raises-price-target-to-400
UBS Upgrades Insulet to Buy, Raises Price ...
11/19/2025 12:26:28

UBS analyst Danielle Antalffy upgrades Insulet (NASDAQ:PODD) from Neutral to Buy and raises the price target from $355 to $400.

btig-reiterates-buy-on-insulet-maintains-370-price-target
BTIG Reiterates Buy on Insulet, Maintains ...
11/13/2025 10:42:44

BTIG analyst Marie Thibault reiterates Insulet (NASDAQ:PODD) with a Buy and maintains $370 price target.

watching-insulet-shares-see-volume-to-the-upside-hearing-investor-business-daily-swingtrader-buys-stock
Watching Insulet; Shares See Volume To The...
11/12/2025 19:13:55

canaccord-genuity-maintains-buy-on-insulet-raises-price-target-to-428
Canaccord Genuity Maintains Buy on Insulet...
11/07/2025 22:04:37

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $399 ...

rbc-capital-maintains-outperform-on-insulet-raises-price-target-to-370
RBC Capital Maintains Outperform on Insule...
11/07/2025 19:08:17

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $365 to ...

wells-fargo-maintains-overweight-on-insulet-raises-price-target-to-360
Wells Fargo Maintains Overweight on Insule...
11/07/2025 18:45:55

Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $3...

ubs-maintains-neutral-on-insulet-raises-price-target-to-355
UBS Maintains Neutral on Insulet, Raises P...
11/07/2025 17:48:28

UBS analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $320 to $355.

truist-securities-reiterates-buy-on-insulet-raises-price-target-to-390
Truist Securities Reiterates Buy on Insule...
11/07/2025 16:31:48

Truist Securities analyst Richard Newitter reiterates Insulet (NASDAQ:PODD) with a Buy and raises the price target from $365...

barclays-maintains-equal-weight-on-insulet-raises-price-target-to-316
Barclays Maintains Equal-Weight on Insulet...
11/07/2025 15:27:21

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $301 to $316.

jefferies-maintains-buy-on-insulet-raises-price-target-to-400
Jefferies Maintains Buy on Insulet, Raises...
11/06/2025 21:35:26

Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $375 to $400.

insulet-sees-q4-sales-746875m-764800m-vs-728218m-est
Insulet Sees Q4 Sales $746.875M-$764.800M ...
11/06/2025 11:44:20

2025 Outlook:For the quarter and year ending December 31, 2025, the Company is providing the following guidance (revenue in con...

insulet-raises-fy2025-sales-guidance-from-2569b-2631b-to-2652b-2672b-vs-2626b-est
Insulet Raises FY2025 Sales Guidance from ...
11/06/2025 11:33:23

2025 Outlook:For the quarter and year ending December 31, 2025, the Company is providing the following guidance (revenue in con...

insulet-q3-adj-eps-124-beats-114-estimate-sales-706300m-beat-676726m-estimate
Insulet Q3 Adj. EPS $1.24 Beats $1.14 Esti...
11/06/2025 11:30:59

Insulet (NASDAQ:PODD) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.14 by 8.96...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

barclays-maintains-equal-weight-on-insulet-raises-price-target-to-301
Barclays Maintains Equal-Weight on Insulet...
11/05/2025 17:31:58

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $300 to $301.

examining-the-future-insulets-earnings-outlook
Examining the Future: Insulet's Earnings O...
11/05/2025 15:02:22

insulet-uber-and-a-financial-stock-on-cnbcs-final-trades
Insulet, Uber And A Financial Stock On CNB...
11/05/2025 13:26:18

Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION